0001104659-24-004155.txt : 20240116
0001104659-24-004155.hdr.sgml : 20240116
20240116170342
ACCESSION NUMBER: 0001104659-24-004155
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240111
FILED AS OF DATE: 20240116
DATE AS OF CHANGE: 20240116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Saggar Rajeev
CENTRAL INDEX KEY: 0001935638
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39724
FILM NUMBER: 24535866
MAIL ADDRESS:
STREET 1: 419 DAVIS DRIVE
STREET 2: SUITE 100
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Liquidia Corp
CENTRAL INDEX KEY: 0001819576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 851710962
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 419 DAVIS DRIVE, SUITE 100
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
BUSINESS PHONE: 919.328.4400
MAIL ADDRESS:
STREET 1: 419 DAVIS DRIVE, SUITE 100
CITY: MORRISVILLE
STATE: NC
ZIP: 27560
4
1
tm243427-5_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-01-11
0
0001819576
Liquidia Corp
LQDA
0001935638
Saggar Rajeev
419 DAVIS DRIVE, SUITE 100
MORRISVILLE
NC
27560
0
1
0
0
Chief Medical Officer
0
Common Stock
2024-01-11
4
A
0
56492
0
A
220591
D
Performance Stock Units
2024-01-11
4
A
0
56492
0
A
Common Stock
56492
56492
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
25% of the RSUs shall vest on January 11, 2025 and the remaining RSUs shall vest ratably on a quarterly basis over three years thereafter.
Includes (i) 46,052 unvested RSUs of the 93,834 RSUs granted to the Reporting Person on July 18, 2022, (ii) 83,333 RSUs granted to the Reporting Person on January 11, 2023 and (iii) 1,189 shares of common stock acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.
Each performance stock unit ("PSU") converts into one share of the Issuer's common stock.
On January 11, 2024, the Reporting Person was granted 56,492 PSUs. The PSUs shall vest upon the later of (A) the following time-based vesting schedule: 25% of the PSUs shall vest on January 11, 2025 and the remaining PSUs shall vest ratably on a quarterly basis over three years thereafter and (B) the first commercial sale of YUTREPIA by the Issuer.
/s/ Dr. Rajeev Saggar
2024-01-16